Published in J Antimicrob Chemother on January 01, 1993
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
T cell-independent antigens type 2. Annu Rev Immunol (1995) 4.62
Investigation and control of an outbreaks of legionnaires' disease in a district general hospital. Lancet (1981) 3.14
Isolation of Legionella pneumophila from water systems: methods and preliminary results. Br Med J (Clin Res Ed) (1981) 3.08
Persistent calcium elevation correlates with the induction of surface immunoglobulin-mediated B cell DNA synthesis. J Exp Med (1993) 2.88
Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis. BMJ (1999) 2.66
Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens. J Exp Med (1992) 2.47
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev (2000) 2.17
Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol (1996) 2.06
Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2003) 1.91
T cell independent antigens. Curr Opin Immunol (1995) 1.78
Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut (1992) 1.76
Subcutaneous apomorphine as a diagnostic test for dopaminergic responsiveness in parkinsonian syndromes. Lancet (1989) 1.72
Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Mov Disord (2001) 1.61
A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem (1989) 1.58
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Injury risk associated with playing actions during competitive soccer. Br J Sports Med (2002) 1.56
Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol Appl Neurobiol (2003) 1.44
Comparison of disc-diffusion and plate-incorporation susceptibility testing of gram-negative bacilli to ticarcillin, piperacillin and ticarcillin/clavulanate. J Antimicrob Chemother (1989) 1.38
Can urine dipstick testing for urinary tract infection at point of care reduce laboratory workload? J Clin Pathol (2005) 1.37
In vivo activation of naive T cells by antigen-presenting B cells. J Immunol (1994) 1.32
Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant (2000) 1.32
Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy. Neurology (2009) 1.26
Bromocriptine in Parkinson's disease. Br J Hosp Med (1978) 1.22
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? J Neurol Neurosurg Psychiatry (2000) 1.14
Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J Biol Chem (1993) 1.13
Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand (1995) 1.13
Intranasal apomorphine: a new treatment in Parkinson's disease. J Neurol Neurosurg Psychiatry (1990) 1.13
Understanding and measuring coordination and control in kicking skills in soccer: implications for talent identification and skill acquisition. J Sports Sci (2000) 1.13
B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae. J Immunol (2000) 1.11
In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions. J Immunol (1999) 1.10
A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol (2001) 1.10
Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations. Lancet (1987) 1.09
Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. Infect Immun (2002) 1.09
Comparison of Sentinel and Bactec blood culture systems. J Clin Pathol (1992) 1.08
Cutaneous infection with Mycobacterium abscessus. Br J Dermatol (1995) 1.08
Reaction of Tris(2-carboxyethyl)phosphine (TCEP) with maleimide and alpha-haloacyl groups: anomalous elution of TCEP by gel filtration. Anal Biochem (2000) 1.06
Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits. J Psychopharmacol (1998) 1.06
Comparative in vitro analysis of proliferation, Ig secretion, and Ig class switching by murine marginal zone and follicular B cells. J Immunol (1993) 1.05
Muscle fatigue induced by exercise simulating the work rate of competitive soccer. J Sports Sci (2003) 1.04
Cross-sectional investigation of indices of isokinetic leg strength in youth soccer players and untrained individuals. Scand J Med Sci Sports (2008) 1.02
Brevin and vitamin D binding protein: comparison of the effects of two serum proteins on actin assembly and disassembly. Biochemistry (1984) 1.01
The functional demands on the intact limb during walking for active trans-femoral and trans-tibial amputees. Prosthet Orthot Int (2000) 1.00
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism. J Neurol Neurosurg Psychiatry (1979) 0.99
Measuring quality of life in PSP: the PSP-QoL. Neurology (2006) 0.96
Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psychiatry (2005) 0.96
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset. Neurosci Lett (1984) 0.96
Clinical genetics of familial progressive supranuclear palsy. Brain (1999) 0.95
No pathogenic mutations in the synphilin-1 gene in Parkinson's disease. Neurosci Lett (2001) 0.95
The neurology of obsessional slowness. Brain (1991) 0.94
Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites. Infect Immun (1993) 0.94
Purification of a variant-specific surface protein of Giardia lamblia and characterization of its metal-binding properties. J Biol Chem (1995) 0.94
IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J Immunol (1993) 0.93
The epidemiology of Yersinia enterocolitica infection in the British Isles 1983-1988. Contrib Microbiol Immunol (1991) 0.92
Collaborative investigation of an outbreak of Salmonella enterica serotype Newport in England and Wales in 2001 associated with ready-to-eat salad vegetables. Commun Dis Public Health (2002) 0.92
Infective endocarditis caused by Kingella denitrificans. J Clin Pathol (1984) 0.92
Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2. Infect Immun (1998) 0.92
Disentangling the role of the tau gene locus in sporadic tauopathies. Curr Alzheimer Res (2010) 0.91
Biochemical analysis of the immune B cell defect in xid mice. J Immunol (1991) 0.91
Antigen presentation by B lymphocytes to CD4+ T lymphocytes in vivo: importance for B lymphocyte and T lymphocyte activation. Semin Immunol (1992) 0.91
"Agrobacterium yellow group" and Pseudomonas paucimobilis causing peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J Clin Pathol (1985) 0.91
Co-crosslinking Fc epsilon RII/CD23 and B cell surface immunoglobulin modulates B cell activation. Eur J Immunol (1992) 0.89
Induction of B cell apoptosis by co-cross-linking CD23 and sIg involves aberrant regulation of c-myc and is inhibited by bcl-2. Int Immunol (1997) 0.89
Levodopa in the treatment of Parkinson's disease: a consensus meeting. Mov Disord (1999) 0.89
Analysis of tetraplegic reaching in their 3D workspace following posterior deltoid-triceps tendon transfer. Spinal Cord (2010) 0.89
Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol (2001) 0.89
Cohort study of a dual-pathogen point source outbreak associated with the consumption of chicken liver pâté, UK, October 2009. J Public Health (Oxf) (2013) 0.89
Lymphokine control of type 2 antigen response. IL-10 inhibits IL-5- but not IL-2-induced Ig secretion by T cell-independent antigens. J Immunol (1992) 0.89
Developing a prioritisation framework: experiences from a Scottish Health Authority. Health Expect (2001) 0.89
Induction of B cell and T cell tolerance in vivo by anti-CD23 mAb. J Immunol (1994) 0.88
Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG. J Immunol (1993) 0.87
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study. Clin Neuropharmacol (1991) 0.86
Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant. Neuropathol Appl Neurobiol (2014) 0.86
The acquisition of methicillin-resistant Staphylococcus aureus (MRSA) in vascular patients. Eur J Vasc Endovasc Surg (2003) 0.85
Gemella haemolysans: a rare and unusual cause of infective endocarditis. Postgrad Med J (1991) 0.84
Characterization of early activation events in cord blood B cells after stimulation with T cell-independent activators. Pediatr Res (1998) 0.84
Near patient testing for Helicobacter pylori: a detailed evaluation of the Cortecs Helisal Rapid Blood test. Eur J Gastroenterol Hepatol (1997) 0.84
Schizophreniform psychosis and adrenomyeloneuropathy. J R Soc Med (1984) 0.83
Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates. J Immunol (1994) 0.83
A new family with frontotemporal dementia with intronic 10+3 splice site mutation in the tau gene: neuropathology and molecular effects. Neuropathol Appl Neurobiol (2005) 0.82
The effect of even, positive and negative pacing on metabolic, kinematic and temporal variables during breaststroke swimming. Eur J Appl Physiol (2002) 0.82
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy. Mov Disord (1998) 0.82
Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies. Biologicals (2002) 0.82
A study of the reproducibility of three different normalisation methods in intramuscular dual fine wire electromyography of the shoulder. J Electromyogr Kinesiol (1998) 0.82
Stereotaxic injection of kainic acid into the striatum of rats induces synthesis of mRNA for heat shock protein 70. FEBS Lett (1988) 0.81
Isolation of Legionella pneumophila from hospital water systems in Victoria. Med J Aust (1982) 0.81
Exploiting molecular mimicry to broaden the immune response to carbohydrate antigens for vaccine development. Vaccine (2001) 0.81
Recurrence of Listeria monocytogenes meningitis. J Infect (1988) 0.81
Drooling in Parkinson's disease: a novel speech and language therapy intervention. Int J Lang Commun Disord (2001) 0.81
Dystonia and cerebellar ataxia. Mov Disord (1990) 0.80
Mood disorder in women with early breast cancer taking tamoxifen, an estradiol receptor antagonist. An expected or unexpected effect? Ann N Y Acad Sci (1995) 0.80
The effectiveness of a pendulum swing for the development of leg strength and counter-movement jump performance. J Sports Sci (1995) 0.80
Randomized trial of tolcapone versus pergolide as add-on to levodopa therapy in Parkinson's disease patients with motor fluctuations. Mov Disord (2001) 0.80
A biomechanical comparison of the SACH, Seattle and Jaipur feet using ground reaction forces. Prosthet Orthot Int (1995) 0.80